1.2 ML garadacimab-gxii 167 MG/ML Auto-Injector [Andembry]
garadacimab-gxii
RxCUI: 2717182
What the CMS Formulary Data Shows for 1.2 ML garadacimab-gxii 167 MG/ML Auto-Injector [Andembry]
Per the CMS 2026 Part D formulary file, 1.2 ML garadacimab-gxii 167 MG/ML Auto-Injector [Andembry] (RxNorm concept RXCUI 2717182, generic name garadacimab-gxii) appears on 12 distinct formulary files spanning 152 Medicare Part D plan offerings - 3% of enrollable Part D products, selective placement; verify formulary inclusion before enrolling. Tier placement ranges from Tier 1 to Tier 5, with a cross-plan average of Tier 3.9.
Real-world access to 1.2 ML garadacimab-gxii 167 MG/ML Auto-Injector [Andembry] depends on utilization management as much as tier placement: 83.3% of covering formularies require prior authorization. 0% require step therapy. 16.7% apply quantity limits.
Medicare Part D spending dashboard figures are not published for this drug. The plan-by-plan detail below lists exactly which PDP and MA-PD contracts carry 1.2 ML garadacimab-gxii 167 MG/ML Auto-Injector [Andembry] today.
Coverage Details
- Formularies covering
- 12
- Plans covering
- 152
- Coverage rate
- 3%
- Tier range
- Tier 1 – Tier 5
- Average tier
- Tier 4, Non-Preferred
Restrictions
- Prior authorization required
- 83.3% of formularies
- Step therapy required
- 0% of formularies
- Quantity limits
- 16.7% of formularies
Tier Distribution Across Plans
Medicare Advantage Plans (MA-PD) Covering 1.2 ML garadacimab-gxii 167 MG/ML Auto-Injector [Andembry]
100 Medicare Advantage plans with Part D drug coverage include this drug.
Frequently Asked Questions
Is 1.2 ML garadacimab-gxii 167 MG/ML Auto-Injector [Andembry] covered by Medicare Part D?
Yes, 1.2 ML garadacimab-gxii 167 MG/ML Auto-Injector [Andembry] is covered by 152 Medicare Part D plans (3% of all Part D formularies).
What tier is 1.2 ML garadacimab-gxii 167 MG/ML Auto-Injector [Andembry] on Medicare Part D plans?
1.2 ML garadacimab-gxii 167 MG/ML Auto-Injector [Andembry] averages Tier 3.9 across Part D plans, ranging from Tier 1 to Tier 5.
Does 1.2 ML garadacimab-gxii 167 MG/ML Auto-Injector [Andembry] require prior authorization?
83.3% of Part D formularies require prior authorization for 1.2 ML garadacimab-gxii 167 MG/ML Auto-Injector [Andembry]. Step therapy: 0%. Quantity limits: 16.7%.
Read our methodology - how this data is sourced, computed, and verified.